: iStockAnalyst.com Symbols Feed

FDA Calendar Updates: AZN, BMY, OSUR, CPD, INSM,

Thu, 25 Jun 2009 20:26:37 GMT

Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response lette (...)[More...]

Hi-Tech Pharmacal: Hi-Growth at a Value Price

Wed, 28 Jan 2009 18:05:00 GMT

With shares of Home Diagnostics (HDIX) surging by nearly 50% since I profiled the company in mid-December as a turnaround, value play from the ETF Innovators Healthcare Cost Containment Index; a search for compelling values among these companies today led me to generic drug maker Hi-Tech[More...]

Beyond Stem Cells: Healthcare Hot Spots

Mon, 26 Jan 2009 18:09:00 GMT

With the surprise announcement last week by Geron (GERN) that the FDA would allow human clinical trials for embryonic stem cells, all companies in the underlying ETF Innovators Index to track the space are screaming higher again today – led by the company with the biggest gains over the past year, StemCells (STEM). Below are three additional areas and associated companies for investors to consider in the search of the next hot spots in the healthcare sector, including a focus on small/mid-cap companies which have the added potential to be acquired as part of renewed M&A in the sector this year. Molecular Diagnostics EXACT Sciences (EXAS) has rejected the hostile $1.50 all-stock offer from[More...]

In Search of Healthcare Diamonds In The Rough

Mon, 12 Jan 2009 04:52:00 GMT

While we are not even halfway through January, the healthcare sector is already active with deal-making, ranging from the rumored $95 buyout of biotech giant Genetech (DNA) by Roche (RHHBY) to Endo's (ENDP) purchase of small-cap, specialty pharma Indevus (IDEV) to Sequenom's (SQNM) $41M offer for emerging diagnostic company EXACT Sciences (EXAS) – which was promptly rebuffed by EXACT's board after the market close on Monday on the promise of a better deal in the works for shareholders. Larger bio-pharma and diagnostic companies are opportunistically looking to expand their product offerings, pipeline prospects, patent portfolios, and drug discovery technology platforms given the huge declines in the stock prices of small/micro-cap stocks in the healthcare sector. With that in mind, I sorted through the ETF Innovators indexes for a list of a dozen[More...]

Five Healthcare Stocks for a Happy New Year

Tue, 23 Dec 2008 13:27:00 GMT

The accompanying table includes a basket of five small-cap stocks chosen from the ETF Innovators (ETFI) new healthcare indexes. The five companies are trading above their 50-day moving averages with expected upside catalyst(s) in the next six months or less. AMAG Pharma (AMAG) announced last evening that the FDA issued another complete response for its iron deficiency anemia drug ferumoxytol (Feraheme). More details are expected today at 8:30 AM (ET) when AMAG[More...]

11 Stocks That Are Going Through The Roof

Thu, 18 Dec 2008 16:25:00 GMT

Sent early to TIMalert subscribers , lots of people banking, don’t you wish you were one of them? 9I do, I didn’t trade at all, but thanks to the success of my instructional DVDs , my... Visit TimothySykes.com to read full article with comments [More...]

10 Hot Stocks, One Of Which I Coulda Woulda Shoulda Bought & Banked aka Hindsight Is Easy

Wed, 17 Dec 2008 17:01:00 GMT

Sent to TIMalert subscribers early this morning, guess I shouldn’t have been such a little baby on ANSV, sometimes you gotta buy a stock up 700% because the percent gain isn’t as... Visit TimothySykes.com to read full article with comments [More...]

Home Diagnostics Offers Value To Diabetics and Investors

Mon, 15 Dec 2008 18:47:00 GMT

With good returns so far since I profiled Caraco Pharma (CPD) as a defensive growth stock at a value price, a related company in the ETF Innovators (ETFI) Global Healthcare Cost Containment Index with similar value parameters is Home Diagnostics (HDIX) – which makes affordable[More...]

6 Hot Stocks To Watch: Market Is This Really The Best You’ve Got ?

Mon, 15 Dec 2008 16:46:00 GMT

Sent to TIMalert subscribers early this morning so they could trade and be prepared instead of the wannabe idiot day traders who come in each day with no plan whatsoever and expect to make $,... Visit TimothySykes.com to read full article with comments [More...]

15 Stocks I’m Looking At Short Selling To Increase My 216% YTD Return

Thu, 11 Dec 2008 16:38:00 GMT

Already successfully shorted one…bringing me to 235% YTD….Jeewwwww Yah! $1800 profit on the day…guess which one….This was sent to TIMalert subscribers early this morning, just... Visit TimothySykes.com to read full article with comments [More...]

Alcohol Distance Variance Ordinance Passes: Tax Rate Public Hearings Set

Fri, 14 Aug 2009 00:46:00 GMT

Aug. 13--Cleburne city council members, by a 3-2 vote, amended the city's alcoholic beverage sale's ordinance on Tuesday.
Council members Dale Sturgeon and Gayle White voted against the proposal.
"This proposal was placed on the agenda at the request of a couple of property owners who were denied permits on the basis of the 300 foot restriction," said City Secretary Shelly Doty.

: iStockAnalyst.com Symbols Feed

FDA Calendar Updates: AZN, BMY, OSUR, CPD, INSM,

Hi-Tech Pharmacal: Hi-Growth at a Value Price

Beyond Stem Cells: Healthcare Hot Spots

In Search of Healthcare Diamonds In The Rough

Five Healthcare Stocks for a Happy New Year

11 Stocks That Are Going Through The Roof

10 Hot Stocks, One Of Which I Coulda Woulda Shoulda Bought & Banked aka Hindsight Is Easy

Home Diagnostics Offers Value To Diabetics and Investors

6 Hot Stocks To Watch: Market Is This Really The Best You’ve Got ?

15 Stocks I’m Looking At Short Selling To Increase My 216% YTD Return

Alcohol Distance Variance Ordinance Passes: Tax Rate Public Hearings Set

U.S. marshals raid Michigan drug company

Some Caraco-brand digoxin tablets recalled

Caraco Pharmaceutical Laboratories, Ltd. Announces Reversal of Summary Judgment in Ultracet(R) ANDA Patent Litigation

Holzer Holzer & Fistel, LLC Announces That a Class Action Lawsuit Has Been Filed on Behalf of Investors in Caraco Pharmaceutical Laboratories, Ltd.

Charles H. Johnson & Associates Announces Filing of Securities Class Action Against Caraco Pharmaceutical Laboratories, Ltd.

Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Imitrex(R) Tablets

Law Offices of Howard G. Smith, Representing Investors of Caraco Pharmaceutical Laboratories, Ltd., Announces Class Action Lawsuit

Shalov Stone Bonner & Rocco LLP Announces Investor Class Action Against Caraco Pharmaceutical Laboratories, Ltd.

Kendall Law Group Announces Class Action Against Caraco Pharmaceutical Laboratories

Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team As Jitendra N. Doshi Assumes Position of CEO

Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010

Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Caraco Pharmaceutical Laboratories, Ltd. (NYSE: CPD)

Form 4 BELL F FOLSOM For: Oct 26 (10K)

Form 3 BELL F FOLSOM For: Oct 26 (10K)

Form 4 BELL F FOLSOM For: Sep 14 (10K)

Form 3 BELL F FOLSOM For: Sep 14 (10K)

Form 3 DOSHI JITENDRA N For: Jul 28 (10K)

Form 4 SUN PHARMA GLOBAL INC For: Jul 30 (10K)

Form 4 CARACO PHARMACEUTICAL For: Jun 16 Filed by: SHANGHVI DILIP S (10K)

Form 4 MANNEY TIM For: Mar 11 (10K)

Form 4 MANNEY TIM For: Feb 24 (10K)

Form 4/A UGEUX GEORGES For: Jan 15 (10K)